| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/14/2009 | WO2009009523A3 Prevention of disulfide bond reduction during recombinant production of polypeptides |
| 05/14/2009 | WO2009009396A9 Bri polypeptides and reducing ab aggregation |
| 05/14/2009 | WO2008140637A3 Secreted staphylococcus aureus proteins and peptides for use in inhibiting activation of the complement system |
| 05/14/2009 | WO2008120107A3 Glycosylation of molecules |
| 05/14/2009 | WO2008100292A3 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 05/14/2009 | WO2008097461A3 Hepcidin and hepcidin antibodies |
| 05/14/2009 | WO2008073884A3 Treating acute renal failure with soluble thrombomodulin variants |
| 05/14/2009 | WO2008064910A9 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 05/14/2009 | WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 05/14/2009 | WO2007148224A8 Polypeptide |
| 05/14/2009 | WO2007059000A3 Modulation of angiogenesis by a-beta peptide fragments |
| 05/14/2009 | WO2007056043A3 Use of potassium channels for identifying compounds that have an insecticidal effect |
| 05/14/2009 | WO2007038056A3 Protease-resistant forms of vegf-d, method of making and method of use |
| 05/14/2009 | WO2007001399A3 Compositions, splice variants and methods relating to cancer specific genes and proteins |
| 05/14/2009 | WO2006060513A3 Toll like receptor 3 antagonists, methods and uses |
| 05/14/2009 | WO2006017621A3 IRAK1c SPLICE VARIANT AND ITS USE |
| 05/14/2009 | WO2005113823A3 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same |
| 05/14/2009 | WO2005113809A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/14/2009 | WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 05/14/2009 | US20090126047 Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time |
| 05/14/2009 | US20090126043 Generation of plants with improved pathogen resistance and drought tolerance |
| 05/14/2009 | US20090126042 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield |
| 05/14/2009 | US20090126040 Plant Vernalization Independence (VIP) Genes, Proteins, and Methods Of Use |
| 05/14/2009 | US20090126034 Environmentally Stable Sensors and Methods of Using the Same |
| 05/14/2009 | US20090124793 Corticotropin releasing factor 2 receptor agonists |
| 05/14/2009 | US20090124792 Fluorescent polymethine cyanine dyes |
| 05/14/2009 | US20090124790 Chromatographic method and system for purifying a botulinum toxin |
| 05/14/2009 | US20090124708 Collagenous tissue compositions |
| 05/14/2009 | US20090124698 Selective estrogen receptor modulator compositions and methods for treatment of disease |
| 05/14/2009 | US20090124592 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 05/14/2009 | US20090124547 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain |
| 05/14/2009 | US20090124546 Antimicrobially Active Peptides |
| 05/14/2009 | US20090124545 Novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 05/14/2009 | US20090124544 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| 05/14/2009 | US20090124543 Activity dependent neurotrophic factor iii (adnf iii) |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090124539 Methods of treating infection |
| 05/14/2009 | US20090124538 Selective R-cadherin antagonists and methods |
| 05/14/2009 | US20090124537 Screening method for bone morphogenetic mimetics |
| 05/14/2009 | US20090124004 Insect desiccation resistance genes and uses thereof |
| 05/14/2009 | US20090124002 Alpha-1d calcium channel expressed in atrium |
| 05/14/2009 | US20090123999 Nucleotide sequences invovled in plant disease resistance |
| 05/14/2009 | US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/14/2009 | US20090123971 Compositions of aminoacyl-tRNA synthetase and uses thereof |
| 05/14/2009 | US20090123970 Glycosylated mammalian ngal and use thereof |
| 05/14/2009 | US20090123969 Novel fluorescent protein and gene encoding the same |
| 05/14/2009 | US20090123967 Modified spider silk proteins |
| 05/14/2009 | US20090123953 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same |
| 05/14/2009 | US20090123949 Methods for determining the prognosis for cancer patients using tucan |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 05/14/2009 | US20090123920 Jak2 mutations |
| 05/14/2009 | US20090123918 Human Protooncogene TRG and Protein Encoded Therein |
| 05/14/2009 | US20090123911 Isolated staphylococcus dnax subunit and use thereof |
| 05/14/2009 | US20090123565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/14/2009 | US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use |
| 05/14/2009 | US20090123498 Treatment of post-stroke muscle pain |
| 05/14/2009 | US20090123497 Chromatographic method and system for purifying a botulinum toxin |
| 05/14/2009 | US20090123496 Purification of hbv antigens for use in vaccines |
| 05/14/2009 | US20090123490 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/14/2009 | US20090123477 Antibodies |
| 05/14/2009 | US20090123476 Targeted binding agents directed to upar and uses thereof |
| 05/14/2009 | US20090123471 T-Cadherin antigen arrays and uses thereof |
| 05/14/2009 | US20090123463 Methods and compositions for inducing apoptosis |
| 05/14/2009 | US20090123462 Fgfr agonists |
| 05/14/2009 | US20090123461 Human podocalyxin alternative-spliced forms and uses thereof |
| 05/14/2009 | US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease |
| 05/14/2009 | US20090123458 having a modified histidine residue with a fluorine at the 2-position so that the pKa of the modified histidine residue is less than about 3; vaccine for the treatment of anthrax |
| 05/14/2009 | US20090123452 Protease screening methods and proteases identified thereby |
| 05/14/2009 | US20090123424 Methods of protein purification and recovery |
| 05/14/2009 | US20090123421 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 05/14/2009 | US20090123417 Recombinant super-compound interferon and uses thereof |
| 05/14/2009 | US20090123381 Imaging and therapeutic targeting of prostate and bladder tissues |
| 05/14/2009 | US20090123371 Molecular signature of cancer |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/14/2009 | CA2742839A1 Novel neurturin conjugates for pharmaceutical use |
| 05/14/2009 | CA2723165A1 Sulfatase enzymes |
| 05/14/2009 | CA2705160A1 Fusion proteins of mannose binding lectins for treatment of disease |
| 05/14/2009 | CA2704845A1 Method for preparing food product |
| 05/14/2009 | CA2704775A1 Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine |
| 05/14/2009 | CA2704745A1 Alpha-amylase variants with altered properties |
| 05/14/2009 | CA2704556A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | CA2704234A1 Modified recombinant factor viii and von willebrand factor and methods of use |
| 05/14/2009 | CA2703395A1 Mycobacterium antigens |
| 05/14/2009 | CA2703099A1 Activin receptor-like kinase-i compositions and methods of use |
| 05/14/2009 | CA2702630A1 Use of lingo-4 antagonists in the treatment of conditions involving demyelination |
| 05/13/2009 | EP2058408A2 Therapeutic GPCR targets in cancer |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058398A1 Production of recombinant human hemoglobin using pichia yeast |
| 05/13/2009 | EP2058395A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 05/13/2009 | EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058331A1 Sugar chain-containing albumin, production method and use thereof |
| 05/13/2009 | EP2058330A1 Insulin derivative |
| 05/13/2009 | EP2058329A1 Improved secretion of neublastin |
| 05/13/2009 | EP2058328A1 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/13/2009 | EP2058327A2 Genes encoding insect odorant receptors and uses thereof |
| 05/13/2009 | EP2058326A1 Method for the purificaiton of G-CSF |
| 05/13/2009 | EP2058325A2 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library. application to the detection of mycobacteria |